Financial News for Savient Pharmaceuticals, Incorporated (SVNT)
| SVNT | 3/18/2010 1:15PM | 52 Week Price Range | Market Capitalization | Dividend Yield | Recent Dividend |
|---|---|---|---|---|---|
| $14.80 | $4.38 — $16.62 | $1.0 Billion | n/a | n/a |
Want to Sharpen Your Investing?
Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.
Explore Why Ockham?
Quality Analysis
Crowd Sentiment
Financial News Slicing
Savient Pharmaceuticals, Inc. was discussed on The Opening Bell on Fox Business
which was originally produced by Fox Business on 2/13/2009
If you are an investor, then The Opening Bell on Fox Business hosted by Alexis Glick on Fox Business is a must watch. Savient Pharmaceuticals, Incorporated was discussed on 2/13/09 show.
Savient Pharmaceuticals, Incorporated is in the news. Find out how this impacts SVNT trading on Ockham Research.
Pricing a secondary common stock offering and investors not necessary lie liking the dilutive effect of the move and SAVIENT PHARMACEUTICALS hit hard and the company announcing fda is reviewing one of its gout drugs and others i'm watching,
“Pricing a secondary common stock offering and investors not necessary lie liking the dilutive effect of the move and SAVIENT PHARMACEUTICALS hit hard and the company announcing fda is reviewing one of its gout drugs and others i'm watching, ” The Opening Bell on Fox Business Feb 13, 2009 9:33 AM
Some important items we've observed:
- SVNT has seen an increase in price by 157.89% since this commentary appeared on Fox Business's The Opening Bell on Fox Business.
- Alexis Glick mentioned quite a few stocks, 25 individual companies to be exact. You can see the all company slices for The Opening Bell on Fox Business on the recap page.
- As far as The Opening Bell on Fox Business on Friday, February 13, 2009, this is the only mention for Savient Pharmaceuticals, Incorporated.
- SVNT has had 1 mentions, on various business television shows, since this one. Find out what was said with the latest financial news on Savient Pharmaceuticals, Incorporated.


